PETROSCRAP.COM

Kadmon Pharmaceuticals and Nano Terra Announce Worldwide Exclusive Licensing Agreement for Three Novel Product …
Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra’s drug discovery platform, Pharmacomer™ Technology.

Read more on Business Wire via Yahoo! Finance

This entry was posted on Tuesday, April 26th, 2011 at 1:34 am and is filed under Polymer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.